CSL Future Growth
Future criteria checks 3/6
CSL is forecast to grow earnings and revenue by 17.9% and 10.3% per annum respectively while EPS is expected to grow by 18.6% per annum.
Key information
17.9%
Earnings growth rate
18.6%
EPS growth rate
Biotechs earnings growth | 0% |
Revenue growth rate | 10.3% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 13 Apr 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2025 | 16,606 | 3,759 | 3,219 | 4,501 | 15 |
6/30/2024 | 15,189 | 3,247 | 2,468 | 3,641 | 16 |
6/30/2023 | 13,407 | 2,424 | 1,141 | 2,377 | 16 |
12/31/2022 | 11,704 | 2,118 | 621 | 2,182 | N/A |
9/30/2022 | 11,133 | 2,186 | 1,001 | 2,406 | N/A |
6/30/2022 | 10,562 | 2,255 | 1,381 | 2,629 | N/A |
3/31/2022 | 10,587 | 2,290 | 1,251 | 2,679 | N/A |
12/31/2021 | 10,612 | 2,325 | 1,121 | 2,728 | N/A |
9/30/2021 | 10,461 | 2,350 | 1,538 | 3,175 | N/A |
6/30/2021 | 10,310 | 2,375 | 1,955 | 3,622 | N/A |
3/31/2021 | 10,145 | 2,520 | 2,127 | 3,597 | N/A |
12/31/2020 | 9,980 | 2,665 | 2,299 | 3,571 | N/A |
9/30/2020 | 9,565 | 2,384 | 1,710 | 3,030 | N/A |
6/30/2020 | 9,151 | 2,103 | 1,121 | 2,488 | N/A |
3/31/2020 | 9,048 | 2,054 | 1,009 | 2,418 | N/A |
12/31/2019 | 8,944 | 2,006 | 897 | 2,347 | N/A |
9/30/2019 | 8,742 | 1,962 | 628 | 1,996 | N/A |
6/30/2019 | 8,539 | 1,919 | 360 | 1,644 | N/A |
3/31/2019 | 8,406 | 1,861 | 426 | 1,621 | N/A |
12/31/2018 | 8,274 | 1,803 | 492 | 1,597 | N/A |
9/30/2018 | 8,094 | 1,766 | 701 | 1,750 | N/A |
6/30/2018 | 7,915 | 1,729 | 910 | 1,902 | N/A |
3/31/2018 | 7,666 | 1,674 | 691 | 1,662 | N/A |
12/31/2017 | 7,417 | 1,618 | 473 | 1,422 | N/A |
9/30/2017 | 7,182 | 1,478 | 430 | 1,335 | N/A |
6/30/2017 | 6,947 | 1,337 | 386 | 1,247 | N/A |
3/31/2017 | 6,802 | 1,333 | 430 | 1,192 | N/A |
12/31/2016 | 6,656 | 1,329 | 474 | 1,138 | N/A |
9/30/2016 | 6,386 | 1,286 | N/A | 1,158 | N/A |
6/30/2016 | 6,115 | 1,242 | N/A | 1,179 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CSL N's forecast earnings growth (17.9% per year) is above the savings rate (7.5%).
Earnings vs Market: CSL N's earnings (17.9% per year) are forecast to grow faster than the MX market (9.2% per year).
High Growth Earnings: CSL N's earnings are forecast to grow, but not significantly.
Revenue vs Market: CSL N's revenue (10.3% per year) is forecast to grow faster than the MX market (6.2% per year).
High Growth Revenue: CSL N's revenue (10.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CSL N's Return on Equity is forecast to be high in 3 years time